The Bone & Joint Journal · 2019 · 34 citations · 20 references
MedicineOrthopaedic SurgerySurgeryJoint Replacement SurgeryOrthopedicsProstheticsBone InfectionsJoint InfectionsOrthopedic InfectionPostoperative Orthopaedic InfectionProsthetic Joint InfectionSurgical Infection ManagementBone Infection SurgeryFungal Joint InfectionFungal Prosthetic Joint InfectionImplant-associated Bone InfectionInfection Risk FactorsJoint Replacement InfectionProsthesis-associated Fungal InfectionRecurrent Infection Management
Aims The aims of this study were to report the efficacy of revision surgery for patients with co-infective bacterial and fungal prosthetic joint infections (PJIs) presenting to a single institution, and to identify prognostic factors that would guide management. Patients and Methods A total of 1189 patients with a PJI were managed in our bone infection service between 2006 and 2015; 22 (1.85%) with co-infective bacterial and fungal PJI were included in the study. There were nine women and 13 men, with a mean age at the time of diagnosis of 64.5 years (47 to 83). Their mean BMI was 30.9 kg/m 2 (24 to 42). We retrospectively reviewed the outcomes of these PJIs, after eight total hip arthroplasties and 14 total knee arthroplasties. The mean clinical follow-up was 4.1 years (1.4 to 8.8). Results The median number of risk factors for PJI was 5.5 (interquartile range (IQR) 3.25 to 7.25). All seven patients who initially underwent debridement and implant retention (DAIR) had a recurrent infection that led to a staged revision. All 22 patients underwent the first of a two-stage revision. None of the nine patients with negative tissue cultures at the second stage had a recurrent infection. The rate of recurrent infection was significantly higher in the presence of multidrug-resistant bacteria (p = 0.007), a higher C-reactive protein (CRP) at the time of presentation (p = 0.032), and a higher number of co-infective bacterial organisms (p = 0.041). The overall rate of eradication of infection after two and five years was 50% (95% confidence interval (CI) 32.9 to 75.9) and 38.9% (95% CI 22.6 to 67), respectively. Conclusion The risk of failure to eradicate infection with the requirement of amputation associated with this diagnosis is much higher than in patients with PJI without bacterial and fungal co-infection, and this risk is heightened when the fungal organism is joined by polymicrobial and multidrug-resistant bacterial organisms. Cite this article: Bone Joint J 2019;101-B:582–588.
20
Javad Parvizi, Benjamin Zmistowski, Elie F. Berbari et al. · Clinical Orthopaedics and Related Research · 2011 · 1.9K citations · Full text
Economic Burden of Periprosthetic Joint Infection in the United States
Steven M. Kurtz, Edmund Lau, Heather Watson et al. · The Journal of Arthroplasty · 2012 · 1.7K citations
Risk Factors for Prosthetic Joint Infection: Case‐Control Study
Elie F. Berbari, Arlen D. Hanssen, M. C. T. Duffy et al. · Clinical Infectious Diseases · 1998 · 842 citations · Full text